These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28881808)

  • 1. CXCL13 is androgen-responsive and involved in androgen induced prostate cancer cell migration and invasion.
    Fan L; Zhu Q; Liu L; Zhu C; Huang H; Lu S; Liu P
    Oncotarget; 2017 Aug; 8(32):53244-53261. PubMed ID: 28881808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AZGP1 is androgen responsive and involved in AR-induced prostate cancer cell proliferation and metastasis.
    Cao R; Ke M; Wu Q; Tian Q; Liu L; Dai Z; Lu S; Liu P
    J Cell Physiol; 2019 Aug; 234(10):17444-17458. PubMed ID: 30820960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory mechanism of androgen receptor on NCAPD3 gene expression in prostate cancer.
    Yin Y; Liu Q; Shao Y; He X; Zhu Q; Lu S; Liu P
    Prostate; 2022 Jan; 82(1):26-40. PubMed ID: 34591337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells.
    Patel D; Chinaranagari S; Chaudhary J
    Am J Cancer Res; 2015; 5(11):3407-21. PubMed ID: 26807321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion.
    Gang X; Wang G; Huang H
    Prostate; 2015 May; 75(6):561-72. PubMed ID: 25631036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3Kp110-, Src-, FAK-dependent and DOCK2-independent migration and invasion of CXCL13-stimulated prostate cancer cells.
    El Haibi CP; Sharma PK; Singh R; Johnson PR; Suttles J; Singh S; Lillard JW
    Mol Cancer; 2010 Apr; 9():85. PubMed ID: 20412587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CA916798 affects growth and metastasis of androgen-dependent prostate cancer cells.
    He J; Lan X; Duan HL; Luo H; Zhou XD
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4477-4487. PubMed ID: 30058677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
    Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
    PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-metastatic effect of GV1001 on prostate cancer cells; roles of GnRHR-mediated Gαs-cAMP pathway and AR-YAP1 axis.
    Kim JW; Park M; Kim S; Lim SC; Kim HS; Kang KW
    Cell Biosci; 2021 Nov; 11(1):191. PubMed ID: 34743733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
    Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
    Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.
    Karacosta LG; Foster BA; Azabdaftari G; Feliciano DM; Edelman AM
    J Biol Chem; 2012 Jul; 287(29):24832-43. PubMed ID: 22654108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ING3 promotes prostate cancer growth by activating the androgen receptor.
    Nabbi A; McClurg UL; Thalappilly S; Almami A; Mobahat M; Bismar TA; Binda O; Riabowol KT
    BMC Med; 2017 May; 15(1):103. PubMed ID: 28511652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLDN8, an androgen-regulated gene, promotes prostate cancer cell proliferation and migration.
    Ashikari D; Takayama KI; Obinata D; Takahashi S; Inoue S
    Cancer Sci; 2017 Jul; 108(7):1386-1393. PubMed ID: 28474805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5.
    Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP
    Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
    Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seleno-aspirin compound AS-10 promotes histone acetylation ahead of suppressing androgen receptor transcription, G1 arrest, and apoptosis of prostate cancer cells.
    Karelia DN; Kim S; Plano D; Sharma AK; Jiang C; Lu J
    Prostate; 2023 Jan; 83(1):16-29. PubMed ID: 35996318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation.
    El-Haibi CP; Singh R; Sharma PK; Singh S; Lillard JW
    Cell Prolif; 2011 Aug; 44(4):311-9. PubMed ID: 21645150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer.
    He HJ; Gu XF; Xu WH; Yang DJ; Wang XM; Su Y
    Acta Pharmacol Sin; 2013 Feb; 34(2):282-8. PubMed ID: 23023312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.